This study will recruit women with post partum pre-eclampsia and match them to controls without postpartum pre-eclampsia to identify an epigenetic signature that is specific to women with post partum pre-eclampsia to help characterize the underlying pathophysiology of post partum pre-eclampsia.
Preeclampsia (PEC) is a heterogeneous disease that complicates 5-8% of pregnancies. Approximately 10% of PEC patients will present with post-partum PEC without having developed the syndrome during the pregnancy (PP-PEC). Management of post-partum preeclampsia (PP-PEC) is challenging because many women do not seek care until neurologic symptoms result from severe-range elevated blood pressure. The pathogenesis and clinical characteristics of PP-PEC are understudied and poorly understood. Identifying clinical risk factors and biomarkers of PP-PEC would help to identify women at risk.
Study Type
OBSERVATIONAL
Enrollment
12
database and epigenetic study
Columbia University Medical Center
New York, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
methylation signature on circulating monocytes
Time frame: 1 week post delivery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.